
Gregory Bisson
Physician · COBIUS HEALTHCARE SOLUTIONS
Credentials: · ·
History
- Present
COBIUS HEALTHCARE SOLUTIONS
- 1998–2000

Research
Systematic review or meta-analysis · The Lancet · 2018 · 504 citations
Tuberculosis and lung damage: from epidemiology to pathophysiology
Review · European Respiratory Review · 2018 · Last of 4 authors · 354 citations
Systematic review or meta-analysis · PLoS ONE · 2011 · 198 citations

25 papers

21 papers

17 papers
- SA
17 papers · 2 as a fellow
- CV
12 papers · 4 as a fellow

10 papers
- HK
10 papers

10 papers
Grants
- 2025–2029
Excess Cardiovascular Inflammation in TB and HIV: EXFIN-TB
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.5M · University of Pennsylvania
- 2025–2027
Fibroblast Activating Protein PET-CT Imaging of TB-Associated Fibrosis
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $446.9K · University of Pennsylvania
- 2022–2027
Inflammation and Fibrosis in Pulmonary TB: The INFIN-TB Study
National Institute of Allergy and Infectious Diseases · R01
PI · $5.1M · Emory University
- 2015–2022
Development of Gleevec for TB and TB/HIV
National Institute of Allergy and Infectious Diseases · UH3
PI · $4.7M · Emory University



